eli lilly zepbound news

Eli Lilly Gets FDA Approval for Zepbound

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.

The Wall Street Journal on MSN · 1d

Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients

Eli Lilly said the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, the first and only prescription medicine for those suffering from this condition.

USA Today · 12h

Eli Lilly to test weight loss drug Zepbound to treat addiction

Weight loss injections have become a popular choice to help people curb their appetite, but can they curb addiction, as well?

STAT11d

Eli Lilly strikes Zepbound deal with Ro, amid questions about future of compounded GLP-1s

Eli Lilly, which has been directing patients to various telehealth sites as it sells its blockbuster obesity medication Zepbound, is broadening its reach, announcing a partnership Wednesday with ...

Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up

As of 11:05 a.m. ET, Novo Nordisk stock is down a disheartening 20.8%, while both Lilly and Viking stocks are up 4.4% apiece.

2don MSN

FDA says knockoff versions of Lilly obesity drug must come off the market

The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes.

1don MSN

Novo Nordisk stock plunges 20% after a trial of its latest weight loss drug disappoints

The Ozempic maker's stock tanked after its highly anticipated CagriSema drug trial showed an average of 22.7% weight loss, ...

This Is Huge News for Eli Lilly Investors

Eli Lilly just gave investors several reasons to cheer.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results